University research records
Hawler Medical University
5 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →5 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Hawler Medical University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–5 of 5 matching records. Counts update as records arrive.
Effects of empagliflozin, sitagliptin and metformin on omentin 1 and resistin in patients with obesity and type 2 diabetes, a prospective study
August 18, 2026 · 0 citations · Open access
Open original record →Anthracycline- and HER2-induced cardiotoxicity: mechanisms, current strategies, and the emerging role of dapagliflozin as a targeted cardioprotective agent
November 4, 2025 · 10 citations · Open access
Open original record →Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study
April 1, 2024 · 4 citations · Open access
Open original record →Meta‐analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus
April 1, 2023 · 18 citations · Open access
Open original record →Harmful versus beneficial effects of using short-term combined oral antidiabetic therapy: An open label comparative clinical trial
May 20, 2021 · 0 citations · Open access
Open original record →